Literature DB >> 15637139

CD4+CD25+ regulatory T cells control induction of autoimmune hemolytic anemia.

Amina Mqadmi1, Xiaoying Zheng, Karina Yazdanbakhsh.   

Abstract

Autoimmune hemolytic anemia (AIHA) is the result of increased destruction of red blood cells (RBCs) due to the production of autoantibodies, and it can be life-threatening. To study the mechanisms that trigger AIHA, we used the Marshall-Clarke and Playfair model of murine AIHA, in which mice repeatedly immunized with rat RBCs develop erythrocyte autoantibodies as well as rat-specific alloantibodies. We analyzed the role of CD25(+) T-regulatory subsets in controlling AIHA in C57/Bl6 mice using antibody depletion studies. Treatment with anti-CD25 antibody but not isotype control prior to immunization with rat RBCs increased the incidence of AIHA from 30% to 90%. Adoptive transfer of purified splenic population of CD4(+)CD25(+) but not CD4(+)CD25(-) cells from immunized mice into naive recipients prevented the induction of autoantibody production. Altogether, our data establish a critical role for CD4(+)CD25(+) cells for control of AIHA, which may help to establish therapeutic strategies for treatment of AIHA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15637139      PMCID: PMC1895013          DOI: 10.1182/blood-2004-12-4692

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Suppressor T cells in experimental autoimmune haemolytic anaemia.

Authors:  A Cooke; P R Hutchings; J H Playfair
Journal:  Nature       Date:  1978-05-11       Impact factor: 49.962

2.  Induction of red cell autoantibodies in normal mice.

Authors:  J H Playfair; S Marshall-Clarke
Journal:  Nat New Biol       Date:  1973-06-13

Review 3.  Induction and regulation of autoimmune hemolytic anemia in mice.

Authors:  K O Cox; A Howles
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

Review 4.  Rat erythrocyte-induced anti-erythrocyte autoantibody production and control in normal mice.

Authors:  J D Naysmith; M G Ortega-Pierres; C J Elson
Journal:  Immunol Rev       Date:  1981       Impact factor: 12.988

5.  Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.

Authors:  Karina Yazdanbakhsh; Stanley Kang; Daniel Tamasauskas; Dorothy Sung; Andromachi Scaradavou
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

6.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment.

Authors:  D M Willerford; J Chen; J A Ferry; L Davidson; A Ma; F W Alt
Journal:  Immunity       Date:  1995-10       Impact factor: 31.745

Review 7.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

  7 in total
  26 in total

1.  T regulatory cells participate in the control of germinal centre reactions.

Authors:  Carla-Maria Alexander; Lorraine T Tygrett; Alexander W Boyden; Kristy L Wolniak; Kevin L Legge; Thomas J Waldschmidt
Journal:  Immunology       Date:  2011-06-03       Impact factor: 7.397

Review 2.  Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.

Authors:  Peter J Bugelski; Pauline L Martin
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 3.  Use of mouse models to study the mechanisms and consequences of RBC clearance.

Authors:  E A Hod; S A Arinsburg; R O Francis; J E Hendrickson; J C Zimring; S L Spitalnik
Journal:  Vox Sang       Date:  2010-03-21       Impact factor: 2.144

Review 4.  Immunopathogenesis of IBD: insufficient suppressor function in the gut?

Authors:  I L Huibregtse; A U van Lent; S J H van Deventer
Journal:  Gut       Date:  2006-10-17       Impact factor: 23.059

5.  Regulatory and Helper Follicular T Cells and Antibody Avidity to Simian Immunodeficiency Virus Glycoprotein 120.

Authors:  Matthew J Blackburn; Ma Zhong-Min; Francesca Caccuri; Katherine McKinnon; Luca Schifanella; Yongjun Guan; Giacomo Gorini; David Venzon; Claudio Fenizia; Nicolò Binello; Shari N Gordon; Christopher J Miller; Genoveffa Franchini; Monica Vaccari
Journal:  J Immunol       Date:  2015-08-21       Impact factor: 5.422

6.  Incomplete depletion and rapid regeneration of Foxp3+ regulatory T cells following anti-CD25 treatment in malaria-infected mice.

Authors:  Kevin N Couper; Daniel G Blount; J Brian de Souza; Isabelle Suffia; Yasmine Belkaid; Eleanor M Riley
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

7.  Biomimetic Targeting of Nanoparticles to Immune Cell Subsets via Cognate Antigen Interactions.

Authors:  Brian T Luk; Yao Jiang; Jonathan A Copp; Che-Ming J Hu; Nishta Krishnan; Weiwei Gao; Shulin Li; Ronnie H Fang; Liangfang Zhang
Journal:  Mol Pharm       Date:  2018-03-16       Impact factor: 4.939

8.  Distinct roles of helper T-cell subsets in a systemic autoimmune disease.

Authors:  Katrina K Hoyer; Wilson F Kuswanto; Eugenio Gallo; Abul K Abbas
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

9.  Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models.

Authors:  Jin Yu; Susanne Heck; Karina Yazdanbakhsh
Journal:  Am J Hematol       Date:  2007-08       Impact factor: 10.047

10.  Regulatory T Cells Control PF4/Heparin Antibody Production in Mice.

Authors:  Yongwei Zheng; Wen Zhu; Dipica Haribhai; Calvin B Williams; Richard H Aster; Renren Wen; Demin Wang
Journal:  J Immunol       Date:  2019-08-30       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.